共 137 条
[1]
Manegold C(2007)Survival improvement in thoracic cancer: progress from the last decade and beyond Lung Cancer 57 S3-S5
[2]
Thatcher N(2004)Abortion surveillance–United States, 2001 MMWR Surveill Summ 53 1-32
[3]
Strauss LT(2010)The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer Chemotherapy 56 417-423
[4]
Herndon J(2010)Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time? J Natl Compr Canc Netw 8 822-832
[5]
Chang J(2010)CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma Biomarkers 15 594-601
[6]
Parker WY(2009)Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer J Thorac Oncol 4 816-821
[7]
Levy DA(2007)Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT J Nucl Med 48 744-751
[8]
Bowens SB(2003)Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 853-863
[9]
Jin B(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216
[10]
Huang AM(2006)FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease Ann Hematol 85 759-767